3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
10
Sarcoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Wilms Tumor
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Tertiary Lymphoid Structures
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Interventions
regorafenib
2
ivosidenib
2
Proton Therapy
2
enasidenib
1
durvalumab
1
capivasertib
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Range of Motion, Articular
1
Pharmacogenomic Testing
1
Paclitaxel
1
Immunoglobulin G
1
HhAntag691
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
tazemetostat
×
1 year
×
Clear all
No trials found.